(NPR) The FDA Has Approved A New Alzheimer's Drug — Here's Why That's Controversial

The FDA Has Approved A New Alzheimer's Drug — Here's Why That's Controversial

class="imagewrap has-source-dimensions"
data-crop-type="wide"
style="
--source-width: 4407;
--source-height: 2478;
"
>

Dr. William Burke goes over a PET brain scan in 2018 at Banner Alzheimers Institute in Phoenix. The drug company Biogen Inc. has received federal approval for a medicine to treat early Alzheimer's disease.



Matt York/AP


hide caption

toggle caption

Matt York/AP

Health

The FDA Has Approved A New Alzheimer's Drug — Here's Why That's Controversial

This is the first new drug approved for Alzheimer's disease since 2003. It's the first to show significant progress against the sticky brain plaques that are the hallmark of Alzheimer's disease.